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Abstract
Objective: To determine the safety and efficacy of a home-based functional
exercise program in spinal and bulbar muscular atrophy (SBMA). Methods:
Subjects were randomly assigned to participate in 12 weeks of either functional
exercises (intervention) or a stretching program (control) at the National Institutes of Health in Bethesda, MD. A total of 54 subjects enrolled, and 50 completed the study with 24 in the functional exercise group and 26 in the
stretching control group. The primary outcome measure was the Adult Myopathy Assessment Tool (AMAT) total score, and secondary measures included
total activity by accelerometry, muscle strength, balance, timed up and go, sitto-stand test, health-related quality of life, creatine kinase, and insulin-like
growth factor-1. Results: Functional exercise was well tolerated but did not lead
to significant group differences in the primary outcome measure or any of the
secondary measures. The functional exercise did not produce significantly more
adverse events than stretching, and was not perceived to be difficult. To determine whether a subset of the subjects may have benefited, we divided them into
high and low functioning based on baseline AMAT scores and performed a post
hoc subgroup analysis. Low-functioning individuals receiving the intervention
increased AMAT functional subscale scores compared to the control group.
Interpretation: Although these trial results indicate that functional exercise had
no significant effect on total AMAT scores or on mobility, strength, balance,
and quality of life, post hoc findings indicate that low-functioning men with
SBMA may respond better to functional exercises, and this warrants further
investigation with appropriate exercise intensity.

Introduction
Spinal and bulbar muscular atrophy (SBMA) is an Xlinked neuromuscular disorder caused by polyglutamine
repeat expansion in the androgen receptor.1,2 SBMA
causes progressive muscle weakness, cramps, and tremor,
with degeneration of motor neurons and muscle.3,4 These
changes often lead to limitations in mobility and in the
capacity to perform functions such as sitting up and
standing from a seated position.5,6 The loss of these abilities leads to greater dependence on caregivers, with associated psychosocial ramifications.

Exercise training has been shown to improve function
in older adults7 and in disease populations.8,9 In humans,
exercise has been shown to increase levels of insulin-like
growth factor-1 (IGF-1),10,11 which alleviates the manifestations of SBMA in transgenic mice.12 These findings suggest that exercise may be beneficial in SBMA.
Clinical studies of the efficacy of exercise training to
improve physical function in persons with neuromuscular
diseases (NMD) have had mixed results. One review
concluded that exercise is likely to be effective in improving function13, whereas others were more equivocal.14
Some discrepancy in these studies may be due to the
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heterogeneity of diagnoses and various degrees of disease
severity included in the studies.15 Interestingly, improvements in physical function after participating in homebased resistance plus balance training have been observed
independent of changes in muscle strength in both elderly
populations16 and subjects with amyotrophic lateral sclerosis.17 A previous trial of aerobic exercise in SBMA conducted with eight subjects did not show a benefit in the
primary outcome measure of maximum oxygen uptake or
in activities of daily living, however, a significant increase
in maximal work capacity was observed.18
To date most trials of exercise interventions in NMD
have used either resistance or aerobic exercises, with little
if any research examining the effects of functional exercise
interventions. Functional exercises are designed to resemble activities typically performed in daily life and are
potentially of greater benefit to patients with activity limitations. The purpose of this study was to examine the
effects of a home-based functional exercise program on
physical function in a cohort of subjects with SBMA and
to evaluate the safety of this approach.

Methods
Overview
We conducted a 12-week, randomized, evaluator-blinded
functional exercise trial at the National Institutes of
Health (NIH) Clinical Center in Bethesda, MD, from July
2011 to January 2014 (Data S1). Subjects were randomly
assigned to either an intervention group that performed a
functional exercise program or a control group that performed a stretching program. Subjects were required to
participate in telephone and video monitoring to ensure
compliance and intervention fidelity. The minimum compliance requirement to be maintained in the study was
completion of 80% of the telephone contact forms and
other communications and 85% of the assigned exercise
sessions.

Subjects
All subjects were men over 18 years of age with genetically
confirmed SBMA. In addition, subjects were required to
have an Adult Myopathy Assessment Tool (AMAT)5 score
from 14 to 41. Subject group randomization was achieved
using stratified block randomization based on AMAT
scores with a block size of four.

Exercise programs
Both the functional exercise and stretching programs were
developed by NIH physical therapists familiar with SBMA
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(Data S2). They were taught by unblinded physical therapy staff. Functional exercises included trunk sit back, sitto-stand (STS), standing squat with theraband row, standing lunge with theraband forward reach, double limb heel
raise, and wall pushup. Maximal functional exercise
capacity for each exercise was assessed by subjects accurately performing as many repetitions as possible in
60 sec. Participants in the functional exercise group began
the first week with one set of exercises performed on two
nonconsecutive days at 50% of the maximal number of
repetitions achieved at baseline in order to assure exercise
safety (Fig. S1). After the first week, the repetitions were
increased to 70% of the maximal baseline performance
for the study duration. At week three, the frequency was
increased to 3 days a week. For weeks 4–6, the subjects
performed two sets of each exercise at each session, and
at week seven they began three sets per session. Subjects
were instructed to keep exercise logs. They were asked to
provide their OMNI rating scale of perceived exertion
(RPE)19,20 and soreness using two different 0–10 point
scales, with 10 indicating the highest level of exertion and
soreness. Exercise subjects were instructed to use the following scale when calculating their weekly RPE: 0–
2 = very easy; 3–4 = easy; 5–6 = starting to get hard; 7–
8 = very hard; 9–10 = so hard I am going to stop. Ratings of soreness were collected with the following scale:
0 = no soreness; 1–3 = mild soreness; 4–6 = moderate
soreness; 7–10 = severe soreness.

Outcomes
Physical function and endurance were measured with the
AMAT5,21 which served as the primary outcome measure
for this study. Quantitative muscle assessment (QMA)
was done by measuring the maximal voluntary isometric
muscle contraction of seven muscles bilaterally, including
shoulder abduction, elbow flexion, hand grip, hip extension, knee extension, ankle dorsi, and plantar flexion.21
Only the right side was analyzed. All muscle strength
data were normalized by body mass index and compared
to control values for calculation of the percent predicted
strength.22–24 The progressive height STS test was modified and used as described by Schenkman et al.25 Mobility was also measured with the Timed Up and Go
(TUG) test and the Actical accelerometer (Philips Respironics, Bend, OR). The Actical was worn during the first
10 days of the trial and during the last 10 days before
the final evaluation.26–28 In order to account for the subjects who did not fully comply with the 10-day wear period, all total variable counts were weighted by dividing
the average value by the total number of days recorded
for each subject. Subjects having ≥6 days of pre- and
post activity data were analyzed. The Computerized
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Dynamic Posturography SMART EquiTest system and a
long force plate (NeuroCom International, Clackamas,
OR) were used for a quantitative assessment of balance.
The Medical Outcomes Study 36-item Short Form version 2 (SF36 v2; Quality Metric software, Lincoln, RI)
was used to assess the health-related quality of life and
the Beck Depression Inventory (BDI) II (Pearson, San
Antonio, TX) was used to screen for depressive symptoms. Blood work was performed at baseline and followup and included assessments of creatine kinase (CK),
IGF-1, and testosterone.
An adverse events questionnaire was administered to
subjects electronically every week to monitor any negative
effects related to exercise, including pain, muscle fatigue,
cramping, and soreness. Additional measures included the
bulbar rating scale (reported as 0–100%) and serological
markers as reported previously by our group.29

Statistical analysis
The sample size needed was calculated based on an anticipated 10% change in the AMAT total score in the intervention group compared to control. This change in
AMAT would be roughly equivalent in magnitude to the
amount of disease progression over 2 years.29 In order to
obtain 80% power with alpha at 0.05 for this study we
kept recruitment open until 50 subjects completed the
study. Groups’ baseline characteristics were compared
with independent sample t-tests. Effects of the intervention were analyzed with a two-way repeated measures
ANOVA on each dependent variable with group (intervention vs. control) as a between factor, and time (pretest vs. posttest) as a within factor. Baseline age, disease
duration, bulbar rating scale, serum IGF-1, testosterone
and CK levels, and functional classification were explored
as potential covariates. Post hoc analyses were performed
to determine the effects of our intervention in subjects
classified as low or high function. Classification was
based on baseline AMAT functional subscale scores
(Low ≤ 15, High > 15). The cutoff of 15 was chosen
because it was the median for both groups. Significance
was established at 0.05, without adjustment for multiple
comparisons.

Exercise in Spinal and Bulbar Muscular Atrophy

Assessed for E ligibility (n= 61 )

Screening Failure (n=7)

Randomized (n= 54)

Functional Exercise (n=27)

Stretching Exercise (n=27)

Discontinued
Discontinued
Non-compliance (n=1)
Family circumstances (n=2)

Final Analysis (n=24 )

Family circumstances (n=1)

Final Analysis (n=26)

Figure 1. Flowchart of the trial. One subject in the functional
exercise group dropped out due to noncompliance with uncompleted
compliance surveys, videos, and weekly exercise forms. Two other
subjects in the functional group and one in the stretching group
dropped out because of family circumstances.

Table 1. Baseline characteristics comparing intervention versus control.

Characteristics
Age (years)
CAG repeat
length
CK (U/L)
IGF1 (ng/mL)
Testosterone,
total (ng/dL)
Disease
duration
(years)
Bulbar
Rating Scale
Body mass
index
QMA total
strength
(% predicted)
QMA UE
strength
QMA LE
strength

Intervention
(n = 24)

Control
(n = 26)

P value

Reference
range

53.8 (10.0)
47.3 (4.9)

56.5 (8.1)
46.9 (2.7)

0.28
0.68

<39

1038 (616)
137.8 (51.1)
385.2 (109.6)

1232 (1171)
155.3 (39.5)
382.4 (153.9)

0.47
0.18
0.94

52–386
87–283
181–758

15.1 (7.5)

16.0 (10.7)

0.11

92.3 (4.1)

92.3 (4.7)

0.99

28.2 (5.1)

28.3 (10.7)

0.61

41.0 (16.9)

39.3 (20.8)

0.68

40.0 (16.0)

36.0 (20.0)

0.97

41.7 (17.6)

41.9 (21.3)

0.41

Results
Patient characteristics
Of 61 subjects screened, seven were not enrolled due to
AMAT total scores above the cutoff, leaving 54 participants entering the trial (Fig. 1). Altogether a total of 50
subjects completed the study and were included in the
analysis, with 24 subjects in the intervention group, and

Data are given as mean (SD). CAG, cytosine adenine guanine; CK,
creatine kinase; IGF-1, insulin-like growth factor 1; QMA, quantitative
muscle assessment; UE, upper extremity; LE, lower extremity.

26 in the stretching control group. Baseline characteristics
are shown in Table 1 and were similar between groups.
All subjects had a high compliance rate of 88.8%. Some
subjects experienced adverse events such as cramping and

Published 2015. This article is a U.S. Government work and is in the public domain in the USA. Annals of Clinical and Translational Neurology published
by Wiley Periodicals, Inc. on behalf of American Neurological Association.

741

Exercise in Spinal and Bulbar Muscular Atrophy

J. A. Shrader et al.

Table 2. Comparisons between intervention versus control groups at pretest versus posttest.
Intervention group

Mobility
AMAT total1 (0–45)
AMAT functional1 (0–21)
AMAT endurance1 (0–24)
STS scale1
(% of knee height)
TUG (sec)1
Actical total activity
(average count per day)1, 2
Molecular
CK (U/L)
IGF-1 (ng/mL)
Testosterone, total (ng/dL)
Overall health
BDI (0–21)
SF36v2 PCS1
SF36v2 MCS1
SF36v2 VT
Strength
QMA total (scaled to BMI)1
QMA upper extremity
QMA lower extremity
Balance
mCTSIB composite (COG
sway velocity in deg/sec)1
MCT composite (latency
in msec)

Control group

Pretest

Posttest

Change

N

Pretest

Posttest

Change

N

P-value

29.3 (6.8)
14.6 (4.0)
14.7 (3.3)
103.3 (22)

29.9 (6.6)
15.3 (3.7)
14.7 (3.6)
103.8 (24.3)

0.6
0.6
0.0
0.4

24
24
24
24

28.9 (6.7)
15.4 (3.4)
13.5 (3.7)
102.3 (22.5)

29.0 (7.7)
15.1 (4.0)
13.9 (4.0)
103.1 (23.5)

0.2
0.3
0.4
0.8

26
26
26
26

0.60
0.08
0.29
0.86

10.8 (6.5)
53,949 (42,610)

11.0 (6.5)
61,797 (48,383)

0.2
7848

24
20

9.5 (3.2)
69,326 (51,539)

9.6 (3.7)
70,498 (50,508)

0.1
1171

26
23

0.93
0.19

1038 (616)
137.8 (51.0)
385.2 (109.6)

1098 (671)
137.6 (54.6)
396.2 (124.3)

61
0.3
10.9

24
24
24

1232 (1174)
155.3 (39.5)
382.4 (153.9)

1153 (1183)
154.0 (41.3)
406.4 (172.5)

79
1.3
24

26
26
26

0.06
0.88
0.57

8.4 (5.6)
32.9 (7.0)
54.6 (9.4)
45.4 (20.6)

8.8 (5.7)
33.0 (7.3)
53.3 (10.0)
46.7 (20.5)

0.3
0.4
1.3
1.4

24
23
23
23

10.6
33.1
53.1
44.5

(8.1)
(6.9)
(12.0)
(20.3)

8.7 (6.7)
34.1 (7.4)
54.4 (10.3)
48.6 (19.5)

1.9
1.0
1.3
4.1

26
26
26
26

0.07
0.74
0.26
0.48

9.26 (2.51)
2.71 (1.17)
6.43 (2.42)

9.08 (2.59)
2.74 (1.15)
6.54 (2.68)

0.18
0.03
0.11

24
24
24

8.77 (3.65)
2.62 (1.14)
6.13 (1.98)

8.93 (3.87)
2.62 (1.19)
5.98 (1.96)

0.16
0.00
0.14

24
25
25

0.08
0.75
0.13

1.5 (0.8)

1.5 (0.7)

0.2

20

1.3 (0.5)

1.3 (0.5)

0.0

23

0.73

154.0 (15.2)

154.3 (15.5)

0.3

21

146.4 (10.4)

149.2 (10.9)

2.8

22

0.23

STS scale utilized seven levels from 80% to 140% of knee height, which was measured from tibial crest to the floor. The SF36v2 is reported as a
norm-based number (0–100 with 50 as the mean) calculated with Quality Metric software (Lincoln, RI). Data are given as mean (SD). AMAT, Adult
Myopathy Assessment Tool; CK, creatine kinase; IGF-1, insulin-like growth factor 1; BDI, Beck Depression Inventory; SF36v2, short form quality of
life survey; PCS, physical component summary; MCS, mental component summary; VT, vitality component; STS, progressive height sit-to-stand
test; TUG, time up and go test; QMA, quantitative muscle assessment; BMI, body mass index; COG, center of gravity; mCTSIB, modified clinical
test of sensory interaction on balance; MCT, motor control test.
1
Classification (low or high function) is a significant covariate.
2
Age is a significant covariate.

falls, which are common in the SBMA population21
(Table S1). There was no significant difference between
the number of adverse events reported by the intervention
and control groups. All but one subject (in the control
group) returned all self-reported questionnaires (one SF36
missing).

Outcome measures
The comparisons between intervention versus control
groups at pretest versus posttest are shown in Table 2.
No significant improvements in the primary outcome
measure, the AMAT total score, or in the AMAT functional and endurance subscales were observed for either
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group. Similarly, no significant changes were observed for
any other measures of mobility, or other outcome categories. Our analysis showed elevation of CK levels in the
intervention group by 61 U/L and the control group
decreasing by 79. RPE reported in the exercise logs were
relatively low for the entire cohort, with a mean score of
3.2  1.5 (week 1), to 3.5  1.5 (week 6), and 3.3  1.6
(weeks 9 and 12). Ratings of soreness after performing
the exercise routine were also low for the entire cohort,
ranging from mean 2.31 (week 1), to 2.14 (week 6), and
2.28 (weeks 9 and 12). Functional variables measured in
the Neurocom force plate including forward lunge, STS,
step up and over, and step quick turn tests were not
reported in the analysis because a great number of data
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were missing due to test floor effect as many patients
were unable to safely perform the tasks.

Post hoc analysis
We found that the AMAT functional subscale baseline
scores (low vs. high function) were a significant covariate
(Table 2), and we therefore carried out post hoc analyses
to determine the influence of functional level on our
cohort’s response to the intervention.
When groups were separated according to baseline
AMAT functional subscale scores (Fig. 2), we found that
individuals with lower AMAT scores who received the
intervention improved physical function as measured by
the AMAT functional subscale, whereas individuals with
similarly low AMAT baseline scores in the stretching control group declined. Figure 2 shows that eight subjects
with low function in the functional exercise intervention group (top left) improved compared to only three
subjects with low function in the control group (bottom

Exercise in Spinal and Bulbar Muscular Atrophy

left). Individuals with higher AMAT baseline functional
subscale scores who received the intervention became
more active, showing an increase in total activity count
per day by accelerometry when compared to the control
group, accounting for age differences (Fig. S2). These
changes in total activity do not appear to be an indication
of the exercise stimulus itself, as the time the intervention
was performed occupied only a small fraction of the total
activity time analyzed (Fig. S3). An independent t-test on
change scores confirmed this finding (P = 0.03).
Additionally, high-function individuals who received
the intervention reported increased depressive symptoms
as measured with the BDI when compared to those in the
control group (group by time interaction F(1,22) = 4.88,
P = 0.04). An independent t-test on change scores confirmed this finding (P = 0.04). It is important to note
that the high-functioning individuals in the control group
had increased depressive symptoms at baseline (Table S2).
There was a borderline difference in average CK change
between the intervention and control groups (P = 0.06).

Figure 2. Change in the functional Adult Myopathy Assessment Tool (AMAT) score following intervention (A) and stretching (B) by individual.
The terms low and high are used to separate the groups of individuals with an initial functional AMAT score below and including 15, classified as
the low function group or above 15, classified as the high function group. Bars above zero indicate an improvement on functional AMAT at
posttest compared to pretest, whereas bars below zero indicate deterioration. No bars indicate that the Functional AMAT score was the same at
posttest compared to pretest. The numbers displayed above or below each bar indicate individual initial functional AMAT score. Within each
group, individuals are ordered by difference in score.
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Six subjects in the intervention group had an increase in
CK by over 200 U/L compared to one subject in the control group. None of the other variables were significantly
different between the groups when individuals were classified as low or high function.

Discussion
Functional exercise is safe and well
tolerated
All subjects achieved a minimum completion rate of 30/
34 exercise sessions. Our analysis showed a modest elevation of CK in the intervention group compared to the
control group, which could reflect more muscle break
down. However, this degree of CK elevation is smaller
than reported in other studies assessing aerobic exercise30
and strength training.31 In addition, RPE during the exercises and soreness after performing the exercise were relatively low for the entire cohort, suggesting that the
exercises were perceived as low intensity. These data coupled with the observation that muscle strength did not
appreciably decline during the study period lead us to
conclude that there was little if any muscle damage.

Functional exercise did not improve the
primary outcome measure
Functional exercise had no significant effect on the total
AMAT, which includes both functional performance and
endurance. Post hoc analyses offered some insights into
why the total AMAT did not capture functional task performance changes in the intervention group, as virtually
all of this groups’ change was seen in the AMAT functional subscale. The lack of change in serum IGF-1 levels
may be related to the time point after exercise that was
tested or the relatively low intensity of exercise. Previous
reports of increased IGF-1 with exercise showed effects
soon after high-intensity cycle ergometry.10,11

Functional exercise may improve functional
task performance in individuals with low
function
While the trial results showed no effect on the total
AMAT, post hoc analysis showed that our cohort had a
wide range of functional levels, which may have influenced intervention response. Individuals with low baseline
function in the intervention group did better than those
with low baseline function in the control group. The
improvement seen in those with lower function was unaccompanied by significant changes in total AMAT, the
endurance subscore, other measures of mobility, strength,
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balance, and quality of life, or biochemical markers. We
do not think this improvement in the low function intervention group resulted from a practice effect since the
high function group did not show a similar improvement.
Several factors could have influenced why those with
high function did not improve functional task performance. Although we attempted to individualize the functional exercise dose, it is possible that those with higher
initial function were underworked. The RPE ratings suggest
the entire cohort felt the intensity of functional exercise
and stretching was light rather than the desired moderate
intensity. Finally, those with high function may have had a
ceiling effect, since those with higher AMAT functional
subscale baseline scores (e.g., 19, 20, or 21), may have had
less room to increase their score, having only one or two
tasks that could be improved upon, given the maximum
possible score of 21. For example, our use of the AMAT
total score with study exclusion criteria above 41, as the
primary outcome measure, did not allow us to appreciate
that nine subjects with functional subscale scores of 19, 20,
and 21 were enrolled. Only one of these nine subjects
improved on the AMAT functional subscale.
In a previous study from our group, the mean total
AMAT score decreased by 9.1% over 2 years.29 The
AMAT functional subscale accounted for over 80% of
that decline, indicating that the functional subscale outperformed the endurance subscale in detecting change in
SBMA (Fernandez-Rhodes et al., unpublished). Additionally, our exercise intervention was designed to improve
upright functional tasks with less emphasis on improving
endurance. Given these considerations, we felt it was
appropriate to explore the analysis of the AMAT functional subscale alone.
Our results also show that high function individuals performing exercise increased their activity during the last
10 days of the study period compared with the first
10 days, in comparison with those who performed stretching. We believe this improvement was not related to activity measurement during the intervention itself since the
intervention sessions represented a small segment of each
10-day measurement period, and no significant increase in
activity was observed during the intervention sessions
themselves. Also, the activity increase was not seen in those
with low function who exercised. It is possible that those
with higher functional capacity can increase their activity
level through exercise without measurable effects on their
function or endurance testing.
Surprisingly, depressive symptoms increased in those
with high function at baseline who received the intervention. BDI scores indicate that these individuals were not
depressed initially, but ended the trial with higher scores
indicating mild depressive symptoms. This finding may
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be related to the high BDI scores in the control group at
baseline and subsequent improvement in scores within
this group. It is also possible that the intervention may
have contributed to increased depression by requiring
men with relatively high, and yet abnormal function and
strength, to perform challenging activities that remind
them of their functional limitations, while those in the
control group performed stretching which may have
improved their overall well-being.

Additional considerations for future studies
In retrospect, a future study could include closer monitoring to achieve a higher intensity exercise for a longer
duration. One may consider powering a study based primarily on functional testing. Advantages of the AMAT
functional subscale include the aforementioned improved
ability to detect functional change in SBMA with the
functional subscale compared with the endurance subscale. Other functional measures are also available, including the newly developed SBMA-FRS.32 On the other
hand, studies examining aerobic exercise, may consider
powering based primarily on endurance scales. Nevertheless, careful consideration should be taken when choosing
a primary outcome measure so that the study population
fits within the dynamic range of the measure.
In this study and in previous work by our group, we
detected that core strength could be diminished in SBMA
as evidenced by difficulty in performing the sit-up task.5
The exercise regimen in this trial included careful instruction to focus on contracting trunk muscles in an attempt
to maintain a stable core during all functional exercises,
but we did not include a direct measure of core strength.

Exercise in Spinal and Bulbar Muscular Atrophy

strength, balance, or quality of life when compared to
stretching in a wide functional range of subjects with
SBMA. However, functional exercise had a favorable safety
profile, and post hoc analysis indicates that functional exercise may improve task performance in those with low baseline function. Subjects with high baseline function had an
increase in overall activity, but also an increase in depressive symptoms. Further studies should consider longer trial
duration, higher intensity exercise, use of function-based
scales as appropriate, and a more targeted study population
to reduce group variability when assessing outcomes in
interventions designed to improve functional task performance.
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Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Figure S1. Twelve weeks of exercise intervention.
Figure S2. Post hoc comparison of total activity level
between intervention and control group. Change in accelerometer total activity count following intervention (A)
and stretching (B) by individual. The terms low and high
are used to separate the groups of individuals with an initial functional AMAT score below and including 15, classified as the low function group or above 15, classified as
the high function group. Bars above zero indicate an
improvement in total activity at posttest compared to
pretest, whereas bars below zero indicate deterioration.
The numbers displayed above or below each bar indicate
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the total activity count. Within each group, individuals
are ordered by difference in activity.
Figure S3. Representative accelerometer activity counts
during the beginning and end of intervention. Data show
the activity counts from a representative individual during
the initial and final days of study intervention. All subjects were instructed to record the time of the intervention by depressing a button on the accelerometer device.
Arrows indicate the 1 h time intervals during which the
intervention was performed. Activity data during this
hour are indicated in black.
Table S1. Adverse events reported by more than 10% of
subjects in either group. Data are the number of subjects
reporting each adverse event, with the number of events
shown in parentheses. P values are for comparison of
the number of subjects reporting adverse events with
stretching or functional exercises, based on chi-square
analysis.
Table S2. Baseline characteristics comparing low function
versus high function individuals under each group (intervention and control). CK, creatine kinase; IGF1, insulinlike growth factor 1; QMA, quantitative muscle assessment. *P < 0.05.
Data S1. Clinical protocol. Effect of functional exercise in
patients with spinal bulbar muscular atrophy.
Data S2. Description of stretching and functional exercises.
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